Literature DB >> 18580479

In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses.

Jingjing Wu1, Shounan Yi, Li Ouyang, Elvira Jimenez, Denbigh Simond, Wei Wang, Yiping Wang, Wayne J Hawthorne, Philip J O'Connell.   

Abstract

BACKGROUND: Cellular rejection of xenografts is predominantly mediated by CD4 T cells. Little is known of the effectiveness of CD4CD25 T regulatory (Treg) cells at suppressing this strong T-cell mediated immune response. In this study, we evaluated the activity of fresh Treg cells and expanded Treg cells to suppress the xeno immune response in vitro.
METHODS: Human Treg cells were preferentially expanded by CD3/CD28 expand beads, interleukin (IL)-2, and rapamycin. Human CD4CD25 T cells were stimulated with irradiated porcine peripheral blood mononuclear cells in the presence or absence of fresh or expanded human Treg cells for 5 days before proliferation assay. In a separate experiment, the porcine xenoantigen-stimulated CD4CD25 T cells were separated from Treg cells by transwells and assessed for cytotoxicity of porcine peripheral blood mononuclear cells target cells. Cytokine-producing cells and cytokine release in the cocultures were examined by enzyme-linked immunosorbent spot and enzyme-linked immonosorbent assay, respectively.
RESULTS: Human Treg were expanded up to 3,500-fold after 14 days in culture. The addition of fresh Treg suppressed the T-cell mediated xenoimmune response. Compared with fresh Treg cells, expanded Treg cells were more potent at suppressing CD4CD25 T-cell-mediated antiporcine xenogeneic responses. This suppression required cell contact. However, the enhanced suppression by expanded Treg cells was associated with increased secretion of IL-4 and IL-10 when compared with their nonexpanded Treg counterparts.
CONCLUSION: This study shows that expanded human Treg cells were capable of suppressing antiporcine xenogeneic responses in vitro and involve both contact dependent and cytokine mediated mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18580479     DOI: 10.1097/TP.0b013e3181734793

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model.

Authors:  Jonathan M Fishman; Mark W Lowdell; Luca Urbani; Tahera Ansari; Alan J Burns; Mark Turmaine; Janet North; Paul Sibbons; Alexander M Seifalian; Kathryn J Wood; Martin A Birchall; Paolo De Coppi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

Review 2.  Immunological challenges and therapies in xenotransplantation.

Authors:  Marta Vadori; Emanuele Cozzi
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

Review 3.  Clinical lung xenotransplantation--what donor genetic modifications may be necessary?

Authors:  David K C Cooper; Burcin Ekser; Christopher Burlak; Mohamed Ezzelarab; Hidetaka Hara; Leela Paris; A Joseph Tector; Carol Phelps; Agnes M Azimzadeh; David Ayares; Simon C Robson; Richard N Pierson
Journal:  Xenotransplantation       Date:  2012 May-Jun       Impact factor: 3.907

4.  Large-scale in vitro expansion of human regulatory T cells with potent xenoantigen-specific suppression.

Authors:  Xi Jin; Yanrong Lu; Ye Zhao; Shounan Yi
Journal:  Cytotechnology       Date:  2015-01-22       Impact factor: 2.058

Review 5.  Regenerative immunology: the immunological reaction to biomaterials.

Authors:  Paolo Cravedi; Samira Farouk; Andrea Angeletti; Lauren Edgar; Riccardo Tamburrini; Jerome Duisit; Laura Perin; Giuseppe Orlando
Journal:  Transpl Int       Date:  2017-10-05       Impact factor: 3.782

6.  Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice.

Authors:  Shounan Yi; Ming Ji; Jingjing Wu; Xiaoqian Ma; Peta Phillips; Wayne J Hawthorne; Philip J O'Connell
Journal:  Diabetes       Date:  2012-03-08       Impact factor: 9.461

7.  A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35.

Authors:  Mingqian Li; Judith Eckl; Christiane Geiger; Dolores J Schendel; Heike Pohla
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

8.  The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients.

Authors:  Liang Ma; Huimao Zhang; Kebang Hu; Guoyue Lv; Yaowen Fu; Desalegn Admassu Ayana; Pingwei Zhao; Yanfang Jiang
Journal:  BMC Immunol       Date:  2015-09-23       Impact factor: 3.615

Review 9.  Kidney xenotransplantation.

Authors:  Peter J Cowan; David K C Cooper; Anthony J F d'Apice
Journal:  Kidney Int       Date:  2013-10-02       Impact factor: 10.612

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.